Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bound

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Clinical Nutrition (Edinburgh, Scotland)|December 26, 2018
Title: Differentiating the effects of whey protein and guar gum preloads on postprandial glycemia in type 2 diabetesLinda E Watson, Liza K Phillips, Tongzhi Wu, et al.
Diabetes Care|January 21, 2016
A Protein Preload Enhances the Glucose-Lowering Efficacy of Vildagliptin in Type 2 DiabetesTongzhi Wu, Tanya J Little, Michelle J Bound, et al.
The Journal of Clinical Endocrinology and Metabolism|September 7, 2016
Small Intestinal Glucose Delivery Affects the Lowering of Blood Glucose by Acute Vildagliptin in Type 2 DiabetesTongzhi Wu, Xiang Zhang, Laurence G Trahair, et al.
Diabetes Care|March 5, 2017
Effects of Vildagliptin and Metformin on Blood Pressure and Heart Rate Responses to Small Intestinal Glucose in Type 2 DiabetesTongzhi Wu, Laurence G Trahair, Tanya J Little, et al.
Diabetes, Obesity & Metabolism|June 24, 2025
Metformin slows intestinal glucose absorption in type 2 diabetes, irrespective of the timing of its administrationMalcolm J Borg, Cong Xie, Chang Chen, et al.
The American Journal of Clinical Nutrition|December 14, 2011
Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humansTongzhi Wu, Beiyi R Zhao, Michelle J Bound, et al.
Diabetes, Obesity & Metabolism|December 7, 2018
A whey/guar "preload" improves postprandial glycaemia and glycated haemoglobin levels in type 2 diabetes: A 12-week, single-blind, randomized, placebo-controlled trialLinda E Watson, Liza K Phillips, Tongzhi Wu, et al.
Diabetes, Obesity & Metabolism|July 2, 2024
Randomised comparison of intravenous and subcutaneous routes of glucagon-like peptide-1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetesDaniel R Quast, Dara Lancaster, Cong Xie, et al.
Diabetes|January 6, 2025
Effects of Metformin on Postprandial Blood Pressure, Heart Rate, Gastric Emptying, GLP-1, and Prevalence of Postprandial Hypotension in Type 2 Diabetes: A Double-Blind Placebo-Controlled Crossover StudyDaniel R Quast, Cong Xie, Michelle J Bound, et al.
Diabetes & Vascular Disease Research|December 13, 2016
Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetesSony S Thazhath, Chinmay S Marathe, Tongzhi Wu, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Clinical Nutrition (Edinburgh, Scotland)|December 26, 2018
Title: Differentiating the effects of whey protein and guar gum preloads on postprandial glycemia in type 2 diabetesLinda E Watson, Liza K Phillips, Tongzhi Wu, et al.
Diabetes Care|January 21, 2016
A Protein Preload Enhances the Glucose-Lowering Efficacy of Vildagliptin in Type 2 DiabetesTongzhi Wu, Tanya J Little, Michelle J Bound, et al.
The Journal of Clinical Endocrinology and Metabolism|September 7, 2016
Small Intestinal Glucose Delivery Affects the Lowering of Blood Glucose by Acute Vildagliptin in Type 2 DiabetesTongzhi Wu, Xiang Zhang, Laurence G Trahair, et al.
Diabetes Care|March 5, 2017
Effects of Vildagliptin and Metformin on Blood Pressure and Heart Rate Responses to Small Intestinal Glucose in Type 2 DiabetesTongzhi Wu, Laurence G Trahair, Tanya J Little, et al.
Diabetes, Obesity & Metabolism|June 24, 2025
Metformin slows intestinal glucose absorption in type 2 diabetes, irrespective of the timing of its administrationMalcolm J Borg, Cong Xie, Chang Chen, et al.
The American Journal of Clinical Nutrition|December 14, 2011
Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humansTongzhi Wu, Beiyi R Zhao, Michelle J Bound, et al.
Diabetes, Obesity & Metabolism|December 7, 2018
A whey/guar "preload" improves postprandial glycaemia and glycated haemoglobin levels in type 2 diabetes: A 12-week, single-blind, randomized, placebo-controlled trialLinda E Watson, Liza K Phillips, Tongzhi Wu, et al.
Diabetes, Obesity & Metabolism|July 2, 2024
Randomised comparison of intravenous and subcutaneous routes of glucagon-like peptide-1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetesDaniel R Quast, Dara Lancaster, Cong Xie, et al.
Diabetes|January 6, 2025
Effects of Metformin on Postprandial Blood Pressure, Heart Rate, Gastric Emptying, GLP-1, and Prevalence of Postprandial Hypotension in Type 2 Diabetes: A Double-Blind Placebo-Controlled Crossover StudyDaniel R Quast, Cong Xie, Michelle J Bound, et al.
Diabetes & Vascular Disease Research|December 13, 2016
Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetesSony S Thazhath, Chinmay S Marathe, Tongzhi Wu, et al.
Pageof 6